Triple-negative receptor status and prognosis in the NCIC CTG MA. 21 adjuvant breast cancer trial

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Clinical Oncology

• Publication date

  2008-05-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2008.26.15_SUPPL.550
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Identification of Cancer Stem Cells: Applications for a Spy1 Clinical Trial

  2018cites this paper
• Triple negative breast cancer: adjuvant chemotherapy effect on survival.

  2011cites this paper
• Demographic and clinico-pathological characteristics in patients with triple-negative and non-triple-negative breast cancer

  2011cites this paper
• Aspirin intake may prevent metastasis in patients with triple-negative breast cancer

  2011cites this paper
• Current and emerging treatment options in triple-negative breast cancer

  2011cites this paper
• Neoadjuvant versus adjuvant chemotherapy for triple negative breast cancer.

  2010cites this paper
• ASSOCIATION FOR ACADEMIC SURGERY Neoadjuvant Versus Adjuvant Chemotherapy for Triple Negative Breast Cancer

  2010cites this paper
• BRCA-Aktivität beim triple-negativen Mammakarzinom

  2010cites this paper
• TRIPLE-NEGATIVE BREAST CANCER

  2009cites this paper
• Pharmacotherapy of triple-negative breast cancer

  2009cites this paper
• Triple-negative breast cancer--current status and future directions.

  2009cites this paper